Stay updated on DCDP with or without Pomalidomide Clinical Trial
Sign up to get notified when there's something new on the DCDP with or without Pomalidomide Clinical Trial page.

Latest updates to the DCDP with or without Pomalidomide Clinical Trial page
- Check6 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for a Phase 2 study of daratumumab, cyclophosphamide, and dexamethasone, with pomalidomide used in different ways across the two arms. It includes study design, participant eligibility, locations, and progression-free survival as the primary outcome.SummaryDifference58%

- Check13 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2. The study record still shows a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe study record page now displays a 403 Forbidden response with a Home link, so its trial details are unavailable.SummaryDifference0.5%

Stay in the know with updates to DCDP with or without Pomalidomide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCDP with or without Pomalidomide Clinical Trial page.